Non-Current Assets
Equity Method Investments
Medtronic Equity Method Investments increased by 8.8% to $730M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 9.8%, from $809M to $730M.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
First reportedQ4 2024
Last reportedQ3 2026Feb 24, 2026
Metric ID:
equity_method_investmentsHistorical Data
6 periods
| Q4 '24 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|
| Value | $859M | $809M | $705M | $697M | $671M | $730M |
| QoQ Change | — | -5.8% | -12.9% | -1.1% | -3.7% | +8.8% |
| YoY Change | — | — | -17.9% | — | — | -9.8% |
Range$671M – $859M
CAGR-12.2%
Avg YoY Growth-13.8%
Median YoY Growth-13.8%
Equity Method Investments at Other Companies
Frequently Asked Questions
- What is Medtronic's equity method investments?
- Medtronic (MDT) reported equity method investments of $730M in Q4 2025.
- How has Medtronic's equity method investments changed year-over-year?
- Medtronic's equity method investments decreased by 9.8% year-over-year, from $809M to $730M.